Culture of bone marrow CD105+ cells allows rapid selection of pure BM-stromal cells for chimerism studies in patients undergoing allogeneic bone marrow transplantation [4]

Bone Marrow Transplantation

Volumn 36, Issue 6, 2005, Pages 557-559

  Goussetis, E ^a   Spiropoulos, A ^a   Theodosaki, M ^a   Paterakis, G ^b   Peristeri, I ^a   Kitra, V ^a   Petrakou, E ^a   Soldatou, A ^a   Graphakos, S ^a,c  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b 'G Gennimatas' Athens Hospital   (Greece)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; GLYCOPHORIN A; PADGEM PROTEIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BETA THALASSEMIA; CELL CULTURE; CELL GROWTH; CHIMERA; CLINICAL ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LETTER; MESENCHYMAL STEM CELL; PRIORITY JOURNAL;

ANTIGENS, CD; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; HUMANS; IMMUNOMAGNETIC SEPARATION; RECEPTORS, CELL SURFACE; STROMAL CELLS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 31044434416     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705083     Document Type: Letter

References (10)

1. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Bianco R, Riminucci M, Gronthos S et al. Bone marrow stromal cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
3. Awaya N, Rupert K, Bryant E, Torok-Storb B. Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation. Exp Hematol 2002; 30: 937-942.
4. Cilloni D, Carlo-Stella C, Falzetti F et al. Limited engrafted capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 2000; 96: 3637-3643.
5. Koc ON, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
6. Barry FP, Boytnon RE, Haynesworth S et al. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 1999; 265: 134-139.
7. + population following allogeneic stem cell transplantation. Exp Hematol 2001; 29: 1432-1438.
8. Villaron EV, Ahmeida J, Lüpez-Holgado N et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89: 1421-1427.
9. Scopes J, Ismail M, Marks KJ et al. Correction of stromal cell defect after bone marrow transplantation in aplastic anemia. Br J Haematol 2001; 115: 642-652.
10. Stute N, Fehse B, Schroeder J et al. Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant. J Hematother Stem Cell Res 2002; 11: 977-984.